Randall W. Hungate

2.5k citations

51 papers · 1.4k indexed · h-index 22

Co-authors: Samuel J. Danishefsky Richard Kendall Kenneth A. Thomas Ruth Z. Rutledge Harold G. Selnick Francine E. Wincott David M. Armistead Andrew J. Tebben
Topics: Chemical Synthesis and Analysis (9 papers)HIV/AIDS drug development and treatment (6 papers)Coagulation, Bradykinin, Polyphosphates, and Angioedema (6 papers)
Cited by: Organic Chemistry Toxicology Molecular Biology
Journals: Journal of the American Chemical Society Journal of Biological Chemistry Journal of Medicinal Chemistry
Partner nations: United States China Germany

In The Last Decade

Randall W. Hungate

51 papers receiving 1.3k citations

Peers

Countries citing papers authored by Randall W. Hungate

Since Specialization

Citations

This map shows the geographic impact of Randall W. Hungate's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Randall W. Hungate with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Randall W. Hungate more than expected).

Fields of papers citing papers by Randall W. Hungate

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Randall W. Hungate. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Randall W. Hungate. The network helps show where Randall W. Hungate may publish in the future.

Co-authorship network of co-authors of Randall W. Hungate

This figure shows the co-authorship network connecting the top 25 collaborators of Randall W. Hungate. A scholar is included among the top collaborators of Randall W. Hungate based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Randall W. Hungate. Randall W. Hungate is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Discovery of Phosphodiesterase 10A (PDE10A) PET Tracer AMG 580 to Support Clinical Studies 2016 ·ACS Medicinal Chemistry Letters ·Essa Hu,Ning Chen,Roxanne K. Kunz,Dah‐Ren Hwang,Klaus Michelsen,Carl D. Davis,Ji Ma,Jianxia Shi,(unknown),Randall W. Hungate,James Treanor,Hang Chen,Jennifer R. Allen	4
2	Discovery of dehydro-oxopiperazine acetamides as novel bradykinin B1 receptor antagonists with enhanced in vitro potency 2011 ·Bioorganic & Medicinal Chemistry Letters ·Wenyuan Qian,Jian Jeffrey Chen,(unknown),(unknown),Jiawang Zhu,Kaustav Biswas,(unknown),Randall W. Hungate,Leyla Arik,(unknown),Gondi Kumar,(unknown),Janan Jona,(unknown),(unknown)	7
3	Design and synthesis of novel amide AKT1 inhibitors with selectivity over CDK2 2011 ·Bioorganic & Medicinal Chemistry Letters ·Kate S. Ashton,David J. St. Jean,Steve F. Poon,Matthew R. Lee,John G. Allen,Shiwen Zhang,Julie A. Lofgren,Xiaoling Zhang,Christopher Fotsch,Randall W. Hungate	5
4	2-Aminothiadiazole inhibitors of AKT1 as potential cancer therapeutics 2010 ·Bioorganic & Medicinal Chemistry Letters ·Qingping Zeng,Matthew P. Bourbeau,(unknown),(unknown),Holger Monenschein,(unknown),Matthew R. Lee,Shiwen Zhang,Julie A. Lofgren,Daniel J. Freeman,Chun Li,(unknown),Xin Huang,Douglas W. Hoffman,Harvey Yamane,Andrew S. Tasker,Celia Dominguez,Vellarkad N. Viswanadhan,Randall W. Hungate,Xiaoling Zhang	15
5	Addressing PXR liabilities of phthalazine-based hedgehog/smoothened antagonists using novel pyridopyridazines 2010 ·Bioorganic & Medicinal Chemistry Letters ·Jacob A. Kaizerman,Wade H. Aaron,Songzhu An,Richard J. Austin,Matthew A. Brown,(unknown),Tom Huang,Randall W. Hungate,(unknown),Michael G. Johnson,Gary Lee,Brian S. Lucas,Jessica Orf,Minqing Rong,Maria M. Toteva,Dineli Wickramasinghe,Guifen Xu,Qiuping Ye,Wendy Zhong,Dustin L. McMinn	20
6	Stereoselective Synthesis ofanti-N-Protected 3-Amino-1,2-epoxides by Nucleophilic Addition toN-tert-Butanesulfinyl Imine of a Glyceraldehyde Synthon^† 2009 ·The Journal of Organic Chemistry ·Scott S. Harried,(unknown),Matthew R. Kaller,Patricia López,Wenge Zhong,Randall W. Hungate,Paul J. Reider	19
7	Optimization of novel di-substituted cyclohexylbenzamide derivatives as potent 11β-HSD1 inhibitors 2009 ·Bioorganic & Medicinal Chemistry Letters ·Dustin L. McMinn,Yosup Rew,Athena Sudom,Seb Caille,(unknown),Xiaodong He,Randall W. Hungate,(unknown),Juan C. Jaén,Lisa D. Julian,Jacob A. Kaizerman,(unknown),Daqing Sun,Hua Tu,(unknown),Nigel P.C. Walker,Xuelei Yan,Qiuping Ye,Zhulun Wang,Jay P. Powers	18
8	Discovery of novel hydroxy-thiazoles as HIF-α prolyl hydroxylase inhibitors: SAR, synthesis, and modeling evaluation 2008 ·Bioorganic & Medicinal Chemistry Letters ·Christopher M. Tegley,Vellarkad N. Viswanadhan,Kaustav Biswas,Michael Frohn,(unknown),Catherine Chang,Roland W. Bürli,(unknown),Henrike Veith,Norma Rogers,(unknown),Gloria Biddlecome,Philip Tagari,Jennifer R. Allen,Randall W. Hungate	39
9	Aryl sulfones as novel Bradykinin B1 receptor antagonists for treatment of chronic pain 2008 ·Bioorganic & Medicinal Chemistry Letters ·Kaustav Biswas,(unknown),Wenyuan Qian,(unknown),Jian Jeffrey Chen,(unknown),Randall W. Hungate,Gondi Kumar,Leyla Arik,(unknown),Gloria Biddlecome,Barton H. Manning,Hong Sun,Hong Dong,Ming Huang,Richard Loeloff,(unknown),(unknown)	16
10	Structure-guided design of substituted aza-benzimidazoles as potent hypoxia inducible factor-1α prolyl hydroxylase-2 inhibitors 2008 ·Bioorganic & Medicinal Chemistry Letters ·Mike Frohn,Vellarkad N. Viswanadhan,Alexander J. Pickrell,Jennifer E. Golden,(unknown),Roland W. Bürli,Gloria Biddlecome,(unknown),Norma Rogers,(unknown),Randall W. Hungate,Jennifer R. Allen	22
11	Discovery of a potent and selective c-Kit inhibitor for the treatment of inflammatory diseases 2008 ·Bioorganic & Medicinal Chemistry Letters ·Ning Chen,Roland W. Bürli,Susana Neira,Randall W. Hungate,Dawei Zhang,Violeta Yu,(unknown),Yanyan Tudor,Matthew Plant,(unknown),Kristin L. Meagher,Matthew R. Lee,Xuxia Zhang,Andrea Itano,Michael Schrag,Yang Xu,Gordon Ng,Essa Hu	6
12	Discovery of amido-benzisoxazoles as potent c-Kit inhibitors 2008 ·Bioorganic & Medicinal Chemistry Letters ·Roxanne K. Kunz,(unknown),(unknown),Dawei Zhang,Andrew S. Tasker,Roland W. Bürli,Randall W. Hungate,Violeta Yu,(unknown),Douglas A. Whittington,Kristin L. Meagher,Matthew Plant,Yanyan Tudor,Michael Schrag,Yang Xu,Gordon Ng,Essa Hu	10
13	Discovery of potent LPA2 (EDG4) antagonists as potential anticancer agents 2007 ·Bioorganic & Medicinal Chemistry Letters ·Hilary P. Beck,Todd J. Kohn,Steven M. Rubenstein,(unknown),Ralf Schwandner,(unknown),Kang Dai,Cong Li,Lingming Liang,Holger Wesche,Brendon Frank,(unknown),Dineli Wickramasinghe,Juan C. Jaén,Julio C. Medina,Randall W. Hungate,Shen Wang	36
14	New ‘chemical probes’ to examine the role of the hFPRL1 (or ALXR) receptor in inflammation 2007 ·Bioorganic & Medicinal Chemistry Letters ·Mike Frohn,Han Xu,Xiaoming Zou,Catherine Chang,(unknown),Matthew Plant,Min Wong,Philip Tagari,Randall W. Hungate,Roland W. Bürli	29
15	Potent hFPRL1 (ALXR) agonists as potential anti-inflammatory agents 2006 ·Bioorganic & Medicinal Chemistry Letters ·Roland W. Bürli,Han Xu,Xiaoming Zou,(unknown),Jennifer E. Golden,Mike Frohn,Matthew Adlam,Matthew Plant,Min Wong,Michele McElvain,Kelly Regal,Vellarkad N. Viswanadhan,Philip Tagari,Randall W. Hungate	103
16	Design and synthesis of potent pyridazine inhibitors of p38 MAP kinase 2005 ·Bioorganic & Medicinal Chemistry Letters ·Nuria Tamayo,(unknown),(unknown),David Powers,Yanyan Tudor,Violeta Yu,Lu Min Wong,(unknown),Scot Middleton,Rashid Syed,Timothy S. Harvey,Graham Jang,Randall W. Hungate,Celia Dominguez	40
17	Synthesis and evaluation of thiazole carboxamides as vanilloid receptor 1 (TRPV1) antagonists 2005 ·Bioorganic & Medicinal Chemistry Letters ·Ning Xi,Yunxin Bo,Elizabeth M. Doherty,Christopher Fotsch,Narender R. Gavva,Nianhe Han,Randall W. Hungate,Lana Klionsky,Qingyian Liu,Rami Tamir,Shimin Xu,James Treanor,Mark H. Norman	18
18	Design and synthesis of 1,5-diarylbenzimidazoles as inhibitors of the VEGF-receptor KDR 2003 ·Bioorganic & Medicinal Chemistry Letters ·Mark T. Bilodeau,(unknown),(unknown),(unknown),Kathleen Coll,William R. Huckle,Randall W. Hungate,Richard Kendall,Rosemary C. McFall,Xianzhi Mao,Ruth Z. Rutledge,Kenneth A. Thomas	13
19	Vascular Endothelial Growth Factor Receptor KDR Tyrosine Kinase Activity Is Increased by Autophosphorylation of Two Activation Loop Tyrosine Residues 1999 ·Journal of Biological Chemistry ·Richard Kendall,Ruth Z. Rutledge,Xianzhi Mao,Andrew J. Tebben,Randall W. Hungate,Kenneth A. Thomas	99
20	Rapid X-ray diffraction analysis of HIV-1 protease–inhibitor complexes: inhibitor exchange in single crystals of the bound enzyme 1998 ·Acta Crystallographica Section D Biological Crystallography ·(unknown),(unknown),Yihong Li,David B. Olsen,Mark E. Fraley,Randall W. Hungate,Lawrence C. Kuo	27

About Randall W. Hungate

Randall W. Hungate is a scholar working on Organic Chemistry, Genetics and Virology, having authored 51 papers that have together received 1.4k indexed citations. Recurring topics across this work include Chemical Synthesis and Analysis (9 papers), HIV/AIDS drug development and treatment (6 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (6 papers). The work is most often cited by research in Organic Chemistry (748 citations), Toxicology (36 citations) and Molecular Biology (643 citations). Randall W. Hungate has collaborated with scholars based in United States, China and Germany. Frequent co-authors include Samuel J. Danishefsky, Richard Kendall, Kenneth A. Thomas, Ruth Z. Rutledge, Harold G. Selnick, Francine E. Wincott, David M. Armistead, Andrew J. Tebben, Bruce H. Lipshutz and Mark E. Fraley. Their work appears in journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact